WHAT THIS PAPER ADDS This paper presents the treatment outcomes of critical limb ischemia (CLI) revascularization in patients with endstage renal disease (ESRD) at one institution, compared with the outcomes of patients without ESRD. In this series of patients with CLI, the proportion of patients with ESRD was 43%; this frequency was markedly higher than the frequencies reported in previous studies and contributes to the unique patient profile of the present study. CLI associated with ESRD predicts poor prognosis for limb salvage. The results of this study should facilitate development of a treatment strategy for CLI in patients with ESRD.
INTRODUCTION
The number of patients with end-stage renal disease (ESRD) who are undergoing hemodialysis is increasing worldwide. 1 Peripheral arterial disease is highly prevalent in patients with renal insufficiency. 2 The number of patients with ESRD complicated by critical limb ischemia (CLI) is also growing rapidly and is likely to continue to increase. Therefore, it is imperative to establish an efficacious treatment strategy for CLI associated with ESRD.
Most patients with ESRD have multiple systemic comorbidities and their arteries are affected by severe calcification and multiple distal occlusions 3, 4 that often make bypass surgery extremely challenging. In such patients, surgical arterial reconstruction has primarily been performed for limb salvage. 5 In the present study, the CLI treatment outcomes of patients with and without ESRD were compared and the effectiveness of the surgical intervention was assessed.
PATIENTS AND METHODS

Patient background
This study was conducted according to the guidelines of the research ethics committee of The University of Tokyo Hospital. A total of 184 patients with 213 consecutive CLI episodes due to arteriosclerosis were admitted to the hospital from 2004 to 2010 and were analyzed in the present study. CLI was defined by the presence of ischemic rest pain, nonhealing ulcers, or gangrene along with a foot skin perfusion pressure (SPP) <40 mmHg; SPP was previously demonstrated as an objective method for assessing limb ischemia and predicting wound healing, and, therefore, this parameter is routinely measured in patients with CLI. 6e8 The patients were divided into two groups: patients with ESRD who were undergoing hemodialysis (ESRD group: 79 patients, 101 limbs) and those without ESRD (non-ESRD group: 105 patients, 112 limbs). Only one patient underwent renal transplantation after CLI revascularization. The mean duration of hemodialysis was 7.6 AE 7.3 years (range: 0e33 years) and four patients had a history of peritoneal dialysis. The main causes of ESRD were diabetes mellitus (DM) in 63 (80%), chronic glomerulonephritis in five (6%), nephrosclerosis in three (4%), polycystic kidney disease in two (3%), amyloid nephropathy in one (1%), nephritis gravidarum in one (1%), and unknown in four (5%).
Demographic characteristics and preoperative risk factors are shown in Table 1 . The patients were assumed to have hypertension, dyslipidemia, or DM if they were taking corresponding medications. In Japan, statins are approved by the health insurance system only for dyslipidemia treatment, therefore patients who have been prescribed statins can be considered dyslipidemic. In this study, coronary artery disease (CAD) was defined as greater than 50% stenosis of at least one coronary artery or a definite myocardial infarction. Chronic heart failure (CHF) was defined as a history of treatment for heart failure or an echocardiographic confirmation of cardiac hypofunction, with or without clinical symptoms of heart failure. Cerebrovascular disease (CVD) was defined as a prior stroke or transient ischemic attack 9 ; respiratory impairment was defined as <70% of the forced expiratory volume in 1 second as a percentage of the forced vital capacity or as <80% of the predicted vital capacity. The mean age in the ESRD group was lower than that in the non-ESRD group (p < .0001). DM and CAD were more prevalent in the ESRD group than in the non-ESRD group (p ¼ .001 and .015, respectively). The Fontaine IV ratio was higher in the ESRD group than in the non-ESRD group (p ¼ .038). The ejection fraction (EF) as determined via echocardiography was lower in the ESRD group than in the non-ESRD group (p ¼ .004).
Therapeutic strategy
Systemic organ functioning was thoroughly evaluated preoperatively. Patients with a history or a suspicion of ischemic heart disease or multiple coronary risk factors additionally underwent coronary angiography or coronary computed tomography (CT) scanning. Coronary revascularization was performed preoperatively for cases in which the coronary lesion was considered to carry a high risk of perioperative myocardial ischemia.
The authors have aggressively performed surgical arterial reconstruction for limb salvage in patients with CLI; however, arterial reconstruction was not performed in most cases for which surgery under general anesthesia was considered impossible because of a poor general condition resulting from CAD, CVD, or respiratory impairment. However, revascularization was attempted even in patients with severe systemic dysfunction when surgery was considered feasible under local or block anesthesia. Arterial reconstruction was not indicated when major amputation was inevitable because of an extended infection or necrosis above the heel, in patients who lacked an appropriate arterial site for anastomosis or who lacked a vein graft for distal bypass surgery, or who had a short life expectancy because of cancer or other diseases, and lacked the ability to walk because of a consciousness disorder, paralysis, or contracture. Some patients opted against arterial reconstruction even though surgery was feasible. A contrastenhanced CT or duplex scan was performed 1e2 weeks after surgery and regular graft surveillance, including physical examinations, Doppler pulse ultrasonography, duplex scanning, and CT scanning, was performed every 3e 6 months thereafter to assess the patency of the reconstructed vessels. Limb salvage was defined as relief of rest pain, healing of ischemic lesions, or amputation at the level of the digit or foot. Follow-up evaluations were performed after an average of 28 months (range, 1e103 months), and the 1-year and 2-year follow-up rates were 82% and 62%, respectively.
Surgical procedures
Revascularization was attempted at all levels of the affected limb to restore sufficient blood flow to the foot. Concurrent stenotic or occlusive lesions were usually treated simultaneously. In some cases, complete limb revascularization was not feasible because of poor general conditions or local problems such as infection, extended necrosis, or the absence of an appropriate anastomosis site or autologous vein graft. In the iliac region, endovascular therapy (EVT) was primarily adopted for TransAtlantic Inter-Society Consensus (TASC) A and B lesions, and bypass surgery for TASC C and D lesions. 10 In the infrainguinal region, bypass surgery was primarily adopted and EVT was considered only for localized lesions in the superficial femoral artery. Hybrid procedures that included both EVT and bypass surgery were performed in cases where the lesion ranged over multiple segments. Sub-intimal angioplasty or EVT were not performed in the infrapopliteal region. Preoperatively all patients underwent one or more imaging tests of the affected limb, including intra-arterial digital subtraction angiography, CT angiography, ultrasound, and magnetic resonance (MR) angiography, to evaluate the inflow and runoff vessels. All anastomosis sites were determined on the basis of these examinations. The decision of whether or not to perform bypass surgery was based on the preoperative imaging tests rather than intraoperative angiography. Autologous vein grafts were primarily used for bypass, and prosthetic vascular grafts were used in cases without appropriate autologous vein grafts. Regarding infrainguinal arterial reconstruction, six prosthetic vascular grafts (11%) were used in the ESRD group and 21 (30%) in the non-ESRD group. Reversed saphenous veins were most frequently used as autologous vein grafts and were used in situ in selected cases. Arm veins were used when saphenous veins were not available. a,b There were no significant differences in the primary and secondary graft patency rates between patients with and without ESRD (p ¼ .10 and .17, respectively).
c,d
The overall limb salvage rate was significantly higher in patients who underwent arterial reconstruction than in those who did not (p ¼ .0029 in the ESRD group and <.0001 in the non-ESRD group).
e,f Overall survival was significantly higher in the patients who underwent arterial reconstruction than in those who did not (p ¼ .044 in the ESRD group and .0054 in the non-ESRD group).
g Causes of amputation: necrosis progression, 7 limbs; uncontrolled infection, 4 limbs. h Causes of amputation: necrosis progression, 6 limbs; uncontrolled infection, 10 limbs; uncontrolled pain, 1 limb.
i Cause of amputation: necrosis progression, 3 limbs.
j Causes of amputation: necrosis progression, 8 limbs; uncontrolled infection, 3 limbs; uncontrolled pain, 1 limb. k Causes of death: cardiovascular disease, 4 patients; sepsis, 3 patients; other causes (including gastrointestinal bleeding, non-occlusive mesenteric ischemia, liver failure, peritonitis, and disseminated intravascular coagulopathy), 6 patients.
l Causes of death: cardiovascular disease, 6 patients; cerebrovascular disease, 1 patient; respiratory disease, 1 patient; sepsis, 3 patients; malignancy, 2 patients; other causes (including disseminated intravascular coagulopathy), 2 patients. m Causes of death: cardiovascular disease, 4 patients; cerebrovascular disease, 1 patient; respiratory disease, 2 patients; malignancy, 1 patient; other causes (including disseminated intravascular coagulopathy), 5 patients.
n Causes of death: cardiovascular disease, 6 patients; cerebrovascular disease, 1 patient; other causes (including renal failure, disseminated intravascular coagulopathy, and asphyxiation), 3 patients.
Statistics
The data are presented as mean AE standard deviation (SD) unless otherwise noted. Differences between the groups were analyzed with the Student t test, chi square test, or Fisher's exact test. The graft patency, limb salvage, and survival rates were estimated according to the Kaplane Meier method, and statistical differences were calculated with the log-rank test. A Cox regression analysis was performed on the factors with probability values <.1 in the univariate analysis. Statistical significance was defined as a p value <.05.
RESULTS
Arterial reconstruction was performed in 56 limbs of 46 patients in the ESRD group and 78 limbs of 73 patients in the non-ESRD group; the frequency of those who underwent arterial reconstruction was lower in the ESRD group than in the non-ESRD group (55% vs. 70%; p ¼ .032; Fig. 1 ). Arterial reconstruction was not performed in 45 limbs of 38 patients in the ESRD group and 34 limbs of 34 patients in the non-ESRD group. In the ESRD group, revascularization was not performed in 22 (49%) limbs because of systemic factors such as cardiovascular disease, respiratory dysfunction, ischemic colitis, and malignancy; in 16 (36%) limbs because of local factors such as infection, extended necrosis, anastomosis unsuitability, and graft unavailability; and in seven (15%) limbs for other reasons such as improvement with conservative treatment and patient choice. In the non-ESRD group, arterial reconstruction was not performed in nine (26%) limbs because of systemic factors, eight (24%) limbs because of local factors, and 17 (50%) limbs for other reasons such as improvement with conservative treatment, the patient's decision not to undergo revascularization, and a severely impaired ambulatory status. In most of these patients, even EVT was not indicated because of extensive infection or necrosis or because of the lesion location, extent, or degree of calcification.
The profiles of the patients who did and did not undergo arterial reconstruction are shown in Table 2 . In both the ESRD and non-ESRD groups, those patients who did not undergo revascularization were more likely to have CHF and had a significantly worse EF in comparison with those who did undergo revascularization. There was no difference in the time on hemodialysis comparing those who did with did not undergo arterial reconstruction.
The distribution and TASC II classification of the lesions and the surgical procedures for revascularization are shown in Table 3 . 10 The Bollinger scores of the run-off vessels in patients who underwent bypass grafting were also evaluated. 11, 12 Suprainguinal intervention without infrainguinal revascularization was performed in two limbs in the ESRD group and in six in the non-ESRD group. Distal bypass surgery using autologous vein grafts was performed in 40 limbs (71%) in the ESRD group and 41 (53%) in the non-ESRD group (p ¼ .028). The postoperative outcomes are shown in Fig. 1 . In the ESRD group, major amputation was performed for 11 limbs (20%) during the follow-up period after arterial reconstruction, because of necrosis progression in 5 of 8 limbs (63%) with occluded grafts, and because of uncontrolled infection in 4 of 48 limbs (8%) or necrosis progression in 2 of 48 limbs (4%) with patent grafts. In the non-ESRD group, major amputation was performed for three limbs (4%) after revascularization because of necrosis progression in 2 of 7 limbs (29%) with occluded grafts and in 1 of 71 limbs (1%) with patent grafts. Cardiovascular disease was the most frequent cause of death in both groups. Fatal sepsis was frequent in the ESRD group but was not observed in the non-ESRD group.
A life-table analysis showed that the limb salvage rate after arterial reconstruction was significantly lower in patients with ESRD than in those without ESRD (p ¼ .0019; Fig. 2A ). The postoperative survival rate was lower in the ESRD group when compared with that in the non-ESRD group, although this difference was not significant (p ¼ .052; Fig. 2B ). After arterial reconstruction, the 2-year and 5-year amputation-free survival rates were 60.6% and 48.5%, respectively, in the ESRD group and 88.1% and 75.3%, respectively, in the non-ESRD group (p ¼ .0018; Fig. 2C ). The 2-year and 5-year reintervention free survival rates were 62.0% and 57.2%, respectively, in the ESRD group and 84.4% and 64.4%, respectively, in the non-ESRD group (p ¼ .14; Fig. 2D ). The 1-year and 3-year reintervention rates were 13.9% and 20.0%, respectively, in the ESRD group and 10.4% and 12.8%, respectively, in the non-ESRD group (p ¼ .47).
Arterial reconstruction, including suprainguinal intervention, was performed in 11 limbs in the ESRD group and in 30 in the non-ESRD group. Among these patients, there were no significant differences in the limb salvage rate (80.8% at the 2-year follow-up in the ESRD group vs. 96.4% in the non-ESRD group; p ¼ .10) and the survival rate between patients with and without ESRD (63.6% at the 2-year followup in the ESRD group vs. 92.4% in the non-ESRD group; p ¼ .17). Infrainguinal intervention without suprainguinal revascularization was performed in 45 limbs in the ESRD group and 48 in the non-ESRD group. Among these patients, the limb salvage rate was significantly lower in those with ESRD (81.3% at the 2-year follow-up in the ESRD group vs. 97.9% in the non-ESRD group; p ¼ .014), but there were no significant differences in the survival rate between patients with and without ESRD (82.0% at the 2-year follow-up in the ESRD group vs. 88.6% in the non-ESRD group; p ¼ .34).
After distal bypass surgery, 13 grafts (33%) in the ESRD group were primarily occluded and five were salvaged by segmental graft interposition with an autologous vein. In the non-ESRD group, 10 grafts (24%) were primarily occluded and four were salvaged by catheter thrombectomy, thrombectomy and patch plasty with an autologous 13/15/14/14 40/23/9/6 EVT, endovascular therapy; Ax-F, axillo-femoral bypass; Ao-F, aorto-femoral bypass; F-F crossover, femoro-femoral crossover bypass; TEA, thromboendarterectomy; SFA, superficial femoral artery; F-P, femoropopliteal bypass; PG, bypass surgery using a prosthetic graft; AVG, bypass surgery using an autologous vein graft. a The vessel distal to the distal anastomosis.
vein, percutaneous transcatheter angioplasty, and segmental graft interposition with an autologous vein (one case each). There was no significant difference in the secondary graft patency between patients with and without ESRD (83.3% at the 1-year follow-up and 79.7% at 3-year in the ESRD group vs. 95.1% at 1 year and 86.4% at 3 years in the non-ESRD group; p ¼ .23); however, the limb salvage rate was significantly lower in patients with ESRD (p ¼ .037).
In both groups, the limb salvage rate was significantly lower in patients without arterial reconstruction than in those who underwent surgery (p ¼ .003 and p < .0001 in the ESRD and non-ESRD groups, respectively; Fig. 2E and  F) . A multivariate analysis revealed that the factors independently associated with limb loss in all CLI patients were treatment without arterial reconstruction, male gender, presence of CAD, and an albumin level <3.0 mg/dL; the factors independently associated with limb loss in patients who underwent arterial reconstruction were hemodialysis and the presence of CAD (Table 4) . In both groups, the survival rate was also significantly lower in patients who did not undergo revascularization, compared with those who did (p ¼ .044 and p ¼ .005 in the ESRD and non-ESRD groups, respectively). Treatment without arterial reconstruction and an EF less than 50% were significantly associated with mortality in all CLI patients and in those who underwent arterial reconstruction, respectively (Table 5) .
DISCUSSION
In this series of patients with CLI, the proportion with ESRD (43%) was markedly higher than that in previous reports, 13, 14 contributing to the unique patient profile. The study hospital is a tertiary referral center, and therefore the system of referrals from other hospitals and clinics might have predisposed the results to some bias. In addition, prevalence of ESRD has been reported to be higher in Japan than in other countries. 15 The authors consider these factors to be the reasons behind the relatively high proportion of patients with ESRD. The results demonstrated that patients with ESRD tend to develop CLI at a younger age than patients without ESRD. CLI was more 
0018). (D)
The re-intervention free survival rates of the patients with and without ESRD among those who underwent arterial reconstruction. There was no significant difference in reintervention free survival between the patients with and without ESRD (p ¼ .14). (E) Limb salvage rates of the patients who did and those who did not undergo arterial reconstruction in the ESRD group. The overall limb salvage rate was significantly higher in the patients who underwent arterial reconstruction than in those who did not (p ¼ .003). (F) Limb salvage rates of the patients who did and those who did not undergo arterial reconstruction in the non-ESRD group. The overall limb salvage rate was significantly higher in the patients who underwent arterial reconstruction than in those who did not (p < .0001). The dotted line represents the standard error of the mean >10%. The numbers of at risk patients are listed at the bottom of the graph as follows: patients with ESRD, bottom row; patients without ESRD, top row ( Fig. 2A, B, C and D) , and patients who did not undergo arterial reconstruction, bottom row; patients who underwent arterial reconstruction, top row ( Fig. 2E and F ).
frequently associated with DM, CAD, and reduced cardiac function in patients with ESRD than in those without ESRD. Although the frequency of surgical revascularization was lower in patients with ESRD than in those without ESRD because of systemic and local issues, arterial reconstruction after a thorough evaluation of the systemic organ function resulted in relatively favorable limb salvage and survival rates.
Although arterial reconstruction for limb salvage was aggressively performed, this procedure was not feasible in 45% of the patients with ESRD. In the ESRD group, comorbid severe cardiovascular disease was the most frequent reason for not performing arterial reconstruction. However, only a few severe cardiac events and no cases of cardiovascular death occurred perioperatively during the study period. It is considered, therefore, that a thorough preoperative evaluation of cardiac function and meticulous perioperative management of cardiac disease might have led to favorable outcomes. Infection was the second most frequent reason for not performing arterial reconstruction in the ESRD group. Some patients had already presented with extended necrosis or infection at the time of admission, thus rendering arterial reconstruction impossible. Early CLI detection and management are necessary to provide patients with the opportunity for revascularization.
The authors have attempted to perform surgical revascularization at all levels for patients with ESRD and had previously reported the performance of distal bypass surgery in 11 limbs (40%) of such patients during the period 1991e2000. 5 Since then, the number of patients with ESRD undergoing distal bypass has increased such that distal bypass was performed in 40 limbs (71%) of patients in the ESRD group between 2004 and 2010. Meanwhile, major amputation after revascularization was performed for 11 affected limbs (20%) of patients in the ESRD group, of which four were amputated because of infection despite the presence of patent grafts. Therefore, it is considered that prevention of limb-threatening infection is mandatory to improve limb salvage rates.
In accordance with previous findings, 16e19 the limb salvage rate in the present study was lower in the ESRD group than in the non-ESRD group. Hemodialysis and the presence of CAD were independently associated with limb loss in patients who underwent arterial reconstruction. In contrast, there was no difference in the graft patency rate between the ESRD and non-ESRD groups after distal bypass. Revascularization treatment for CLI in patients with ESRD remains controversial because of poor limb salvage and survival rates, 18,20e23 and some authors have suggested that primary amputation is preferable for patients with ESRD and tissue loss. 17 However, the authors consider that aggressive arterial reconstruction could be beneficial for these patients, given the recent increase in the proportion of long-term survivors among patients with ESRD. Indeed, the present study found no significant difference in the postoperative survival rates of patients with and without ESRD. Conversely, in a previous study, conducted during the period 1991e2000, it was observed that postoperative survival rates were significantly poorer in those with ESRD than in those without ESRD. 5 As reported in previous studies, 24 cardiovascular disease and sepsis were the most frequent causes of death in the ESRD group. CAD was more prevalent in the ESRD group than in the non-ESRD group, and coronary angiography (CAG) indicated that the presence of three-vessel CAD was more frequent in the ESRD group. Therefore, long-term postoperative cardiovascular disease and infection control are essential for improving the treatment outcomes of CLI in patients with ESRD.
The EVT-first strategy is controversial in patients with ESRD. 3, 25 Meanwhile, distal bypass with an autologous vein graft contributes to favorable outcomes even in patients with ESRD. Surgical revascularization should be considered in patients with CLI and ESRD while considering selective approaches that integrate the patient risk, ischemia severity, arterial anatomy, and conduit availability. 26 The main limitations of the present study include its retrospective design and the fact that data were obtained only from a single institution. Therefore, the study results might not reflect the general features of patients with CLI. Further studies regarding prognosis will be needed to determine the appropriate treatment strategy for CLI in patients with ESRD. 
Conclusions
As previously reported, ESRD is a major risk factor for limb loss as well as death. However, surgical revascularization, including distal bypass, can improve the limb prognosis in patients with ESRD who are expected to survive the surgical intervention. Countermeasures against infection are mandatory for improving limb salvage rates. Further studies are needed to establish a treatment strategy for CLI in patients with ESRD.
